Global Regenerative Drugs Market Size, Status and Forecast 2020-2026
SKU ID : QYR-15136385 | Publishing Date : 29-Jan-2020 | No. of pages : 94
Detailed TOC of Global Regenerative Drugs Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Regenerative Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Regenerative Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Synthetic Material
1.4.3 Biologically Derived Material
1.4.4 Genetically Engineered Material
1.4.5 Others
1.5 Market by Application
1.5.1 Global Regenerative Drugs Market Share by Application: 2020 VS 2026
1.5.2 Cardiovascular
1.5.3 Dermatology
1.5.4 Musculoskeletal
1.5.5 Neurology
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Regenerative Drugs Market Perspective (2015-2026)
2.2 Regenerative Drugs Growth Trends by Regions
2.2.1 Regenerative Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Regenerative Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Regenerative Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Regenerative Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Regenerative Drugs Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Regenerative Drugs Players by Market Size
3.1.1 Global Top Regenerative Drugs Players by Revenue (2015-2020)
3.1.2 Global Regenerative Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Regenerative Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Regenerative Drugs Market Concentration Ratio
3.2.1 Global Regenerative Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Regenerative Drugs Revenue in 2019
3.3 Regenerative Drugs Key Players Head office and Area Served
3.4 Key Players Regenerative Drugs Product Solution and Service
3.5 Date of Enter into Regenerative Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Regenerative Drugs Historic Market Size by Type (2015-2020)
4.2 Global Regenerative Drugs Forecasted Market Size by Type (2021-2026)
5 Regenerative Drugs Breakdown Data by Application (2015-2026)
5.1 Global Regenerative Drugs Market Size by Application (2015-2020)
5.2 Global Regenerative Drugs Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Regenerative Drugs Market Size (2015-2020)
6.2 Regenerative Drugs Key Players in North America (2019-2020)
6.3 North America Regenerative Drugs Market Size by Type (2015-2020)
6.4 North America Regenerative Drugs Market Size by Application (2015-2020)
7 Europe
7.1 Europe Regenerative Drugs Market Size (2015-2020)
7.2 Regenerative Drugs Key Players in Europe (2019-2020)
7.3 Europe Regenerative Drugs Market Size by Type (2015-2020)
7.4 Europe Regenerative Drugs Market Size by Application (2015-2020)
8 China
8.1 China Regenerative Drugs Market Size (2015-2020)
8.2 Regenerative Drugs Key Players in China (2019-2020)
8.3 China Regenerative Drugs Market Size by Type (2015-2020)
8.4 China Regenerative Drugs Market Size by Application (2015-2020)
9 Japan
9.1 Japan Regenerative Drugs Market Size (2015-2020)
9.2 Regenerative Drugs Key Players in Japan (2019-2020)
9.3 Japan Regenerative Drugs Market Size by Type (2015-2020)
9.4 Japan Regenerative Drugs Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Regenerative Drugs Market Size (2015-2020)
10.2 Regenerative Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Regenerative Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Regenerative Drugs Market Size by Application (2015-2020)
11 India
11.1 India Regenerative Drugs Market Size (2015-2020)
11.2 Regenerative Drugs Key Players in India (2019-2020)
11.3 India Regenerative Drugs Market Size by Type (2015-2020)
11.4 India Regenerative Drugs Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Regenerative Drugs Market Size (2015-2020)
12.2 Regenerative Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Regenerative Drugs Market Size by Type (2015-2020)
12.4 Central & South America Regenerative Drugs Market Size by Application (2015-2020)
13Key Players Profiles
13.1 Stryker
13.1.1 Stryker Company Details
13.1.2 Stryker Business Overview and Its Total Revenue
13.1.3 Stryker Regenerative Drugs Introduction
13.1.4 Stryker Revenue in Regenerative Drugs Business (2015-2020))
13.1.5 Stryker Recent Development
13.2 Zimmer Biomet Holdings
13.2.1 Zimmer Biomet Holdings Company Details
13.2.2 Zimmer Biomet Holdings Business Overview and Its Total Revenue
13.2.3 Zimmer Biomet Holdings Regenerative Drugs Introduction
13.2.4 Zimmer Biomet Holdings Revenue in Regenerative Drugs Business (2015-2020)
13.2.5 Zimmer Biomet Holdings Recent Development
13.3 Medtronic
13.3.1 Medtronic Company Details
13.3.2 Medtronic Business Overview and Its Total Revenue
13.3.3 Medtronic Regenerative Drugs Introduction
13.3.4 Medtronic Revenue in Regenerative Drugs Business (2015-2020)
13.3.5 Medtronic Recent Development
13.4 Athersys
13.4.1 Athersys Company Details
13.4.2 Athersys Business Overview and Its Total Revenue
13.4.3 Athersys Regenerative Drugs Introduction
13.4.4 Athersys Revenue in Regenerative Drugs Business (2015-2020)
13.4.5 Athersys Recent Development
13.5 STEMCELL Technologies
13.5.1 STEMCELL Technologies Company Details
13.5.2 STEMCELL Technologies Business Overview and Its Total Revenue
13.5.3 STEMCELL Technologies Regenerative Drugs Introduction
13.5.4 STEMCELL Technologies Revenue in Regenerative Drugs Business (2015-2020)
13.5.5 STEMCELL Technologies Recent Development
13.6 Organogenesis
13.6.1 Organogenesis Company Details
13.6.2 Organogenesis Business Overview and Its Total Revenue
13.6.3 Organogenesis Regenerative Drugs Introduction
13.6.4 Organogenesis Revenue in Regenerative Drugs Business (2015-2020)
13.6.5 Organogenesis Recent Development
13.7 Integra Lifesciences
13.7.1 Integra Lifesciences Company Details
13.7.2 Integra Lifesciences Business Overview and Its Total Revenue
13.7.3 Integra Lifesciences Regenerative Drugs Introduction
13.7.4 Integra Lifesciences Revenue in Regenerative Drugs Business (2015-2020)
13.7.5 Integra Lifesciences Recent Development
13.8 Acelity
13.8.1 Acelity Company Details
13.8.2 Acelity Business Overview and Its Total Revenue
13.8.3 Acelity Regenerative Drugs Introduction
13.8.4 Acelity Revenue in Regenerative Drugs Business (2015-2020)
13.8.5 Acelity Recent Development
13.9 Isto Biologics
13.9.1 Isto Biologics Company Details
13.9.2 Isto Biologics Business Overview and Its Total Revenue
13.9.3 Isto Biologics Regenerative Drugs Introduction
13.9.4 Isto Biologics Revenue in Regenerative Drugs Business (2015-2020)
13.9.5 Isto Biologics Recent Development
13.10 CryoLife
13.10.1 CryoLife Company Details
13.10.2 CryoLife Business Overview and Its Total Revenue
13.10.3 CryoLife Regenerative Drugs Introduction
13.10.4 CryoLife Revenue in Regenerative Drugs Business (2015-2020)
13.10.5 CryoLife Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Figures, Tables and Charts Available in Global Regenerative Drugs Market Size, Status and Forecast 2020-2026
List of TablesTable 1. Regenerative Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Regenerative Drugs Revenue
Table 3. Ranking of Global Top Regenerative Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Regenerative Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Synthetic Material
Table 6. Key Players of Biologically Derived Material
Table 7. Key Players of Genetically Engineered Material
Table 8. Key Players of Others
Table 9. Global Regenerative Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Regenerative Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Regenerative Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Regenerative Drugs Market Share by Regions (2015-2020)
Table 13. Global Regenerative Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Regenerative Drugs Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Regenerative Drugs Market Growth Strategy
Table 19. Main Points Interviewed from Key Regenerative Drugs Players
Table 20. Global Regenerative Drugs Revenue by Players (2015-2020) (Million US$)
Table 21. Global Regenerative Drugs Market Share by Players (2015-2020)
Table 22. Global Top Regenerative Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Regenerative Drugs as of 2019)
Table 23. Global Regenerative Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Regenerative Drugs Product Solution and Service
Table 26. Date of Enter into Regenerative Drugs Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Regenerative Drugs Market Size by Type (2015-2020) (Million US$)
Table 29. Global Regenerative Drugs Market Size Share by Type (2015-2020)
Table 30. Global Regenerative Drugs Revenue Market Share by Type (2021-2026)
Table 31. Global Regenerative Drugs Market Size Share by Application (2015-2020)
Table 32. Global Regenerative Drugs Market Size by Application (2015-2020) (Million US$)
Table 33. Global Regenerative Drugs Market Size Share by Application (2021-2026)
Table 34. North America Key Players Regenerative Drugs Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Regenerative Drugs Market Share (2019-2020)
Table 36. North America Regenerative Drugs Market Size by Type (2015-2020) (Million US$)
Table 37. North America Regenerative Drugs Market Share by Type (2015-2020)
Table 38. North America Regenerative Drugs Market Size by Application (2015-2020) (Million US$)
Table 39. North America Regenerative Drugs Market Share by Application (2015-2020)
Table 40. Europe Key Players Regenerative Drugs Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Regenerative Drugs Market Share (2019-2020)
Table 42. Europe Regenerative Drugs Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Regenerative Drugs Market Share by Type (2015-2020)
Table 44. Europe Regenerative Drugs Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Regenerative Drugs Market Share by Application (2015-2020)
Table 46. China Key Players Regenerative Drugs Revenue (2019-2020) (Million US$)
Table 47. China Key Players Regenerative Drugs Market Share (2019-2020)
Table 48. China Regenerative Drugs Market Size by Type (2015-2020) (Million US$)
Table 49. China Regenerative Drugs Market Share by Type (2015-2020)
Table 50. China Regenerative Drugs Market Size by Application (2015-2020) (Million US$)
Table 51. China Regenerative Drugs Market Share by Application (2015-2020)
Table 52. Japan Key Players Regenerative Drugs Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Regenerative Drugs Market Share (2019-2020)
Table 54. Japan Regenerative Drugs Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Regenerative Drugs Market Share by Type (2015-2020)
Table 56. Japan Regenerative Drugs Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Regenerative Drugs Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Regenerative Drugs Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Regenerative Drugs Market Share (2019-2020)
Table 60. Southeast Asia Regenerative Drugs Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Regenerative Drugs Market Share by Type (2015-2020)
Table 62. Southeast Asia Regenerative Drugs Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Regenerative Drugs Market Share by Application (2015-2020)
Table 64. India Key Players Regenerative Drugs Revenue (2019-2020) (Million US$)
Table 65. India Key Players Regenerative Drugs Market Share (2019-2020)
Table 66. India Regenerative Drugs Market Size by Type (2015-2020) (Million US$)
Table 67. India Regenerative Drugs Market Share by Type (2015-2020)
Table 68. India Regenerative Drugs Market Size by Application (2015-2020) (Million US$)
Table 69. India Regenerative Drugs Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Regenerative Drugs Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Regenerative Drugs Market Share (2019-2020)
Table 72. Central & South America Regenerative Drugs Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Regenerative Drugs Market Share by Type (2015-2020)
Table 74. Central & South America Regenerative Drugs Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Regenerative Drugs Market Share by Application (2015-2020)
Table 76. Stryker Company Details
Table 77. Stryker Business Overview
Table 78. Stryker Product
Table 79. Stryker Revenue in Regenerative Drugs Business (2015-2020) (Million US$)
Table 80. Stryker Recent Development
Table 81. Zimmer Biomet Holdings Company Details
Table 82. Zimmer Biomet Holdings Business Overview
Table 83. Zimmer Biomet Holdings Product
Table 84. Zimmer Biomet Holdings Revenue in Regenerative Drugs Business (2015-2020) (Million US$)
Table 85. Zimmer Biomet Holdings Recent Development
Table 86. Medtronic Company Details
Table 87. Medtronic Business Overview
Table 88. Medtronic Product
Table 89. Medtronic Revenue in Regenerative Drugs Business (2015-2020) (Million US$)
Table 90. Medtronic Recent Development
Table 91. Athersys Company Details
Table 92. Athersys Business Overview
Table 93. Athersys Product
Table 94. Athersys Revenue in Regenerative Drugs Business (2015-2020) (Million US$)
Table 95. Athersys Recent Development
Table 96. STEMCELL Technologies Company Details
Table 97. STEMCELL Technologies Business Overview
Table 98. STEMCELL Technologies Product
Table 99. STEMCELL Technologies Revenue in Regenerative Drugs Business (2015-2020) (Million US$)
Table 100. STEMCELL Technologies Recent Development
Table 101. Organogenesis Company Details
Table 102. Organogenesis Business Overview
Table 103. Organogenesis Product
Table 104. Organogenesis Revenue in Regenerative Drugs Business (2015-2020) (Million US$)
Table 105. Organogenesis Recent Development
Table 106. Integra Lifesciences Company Details
Table 107. Integra Lifesciences Business Overview
Table 108. Integra Lifesciences Product
Table 109. Integra Lifesciences Revenue in Regenerative Drugs Business (2015-2020) (Million US$)
Table 110. Integra Lifesciences Recent Development
Table 111. Acelity Business Overview
Table 112. Acelity Product
Table 113. Acelity Company Details
Table 114. Acelity Revenue in Regenerative Drugs Business (2015-2020) (Million US$)
Table 115. Acelity Recent Development
Table 116. Isto Biologics Company Details
Table 117. Isto Biologics Business Overview
Table 118. Isto Biologics Product
Table 119. Isto Biologics Revenue in Regenerative Drugs Business (2015-2020) (Million US$)
Table 120. Isto Biologics Recent Development
Table 121. CryoLife Company Details
Table 122. CryoLife Business Overview
Table 123. CryoLife Product
Table 124. CryoLife Revenue in Regenerative Drugs Business (2015-2020) (Million US$)
Table 125. CryoLife Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Regenerative Drugs Market Share by Type: 2020 VS 2026
Figure 2. Synthetic Material Features
Figure 3. Biologically Derived Material Features
Figure 4. Genetically Engineered Material Features
Figure 5. Others Features
Figure 6. Global Regenerative Drugs Market Share by Application: 2020 VS 2026
Figure 7. Cardiovascular Case Studies
Figure 8. Dermatology Case Studies
Figure 9. Musculoskeletal Case Studies
Figure 10. Neurology Case Studies
Figure 11. Others Case Studies
Figure 12. Regenerative Drugs Report Years Considered
Figure 13. Global Regenerative Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Regenerative Drugs Market Share by Regions: 2020 VS 2026
Figure 15. Global Regenerative Drugs Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Regenerative Drugs Market Share by Players in 2019
Figure 18. Global Top Regenerative Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Regenerative Drugs as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Regenerative Drugs Revenue in 2019
Figure 20. North America Regenerative Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Regenerative Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Regenerative Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Regenerative Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Regenerative Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Regenerative Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Regenerative Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Stryker Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Stryker Revenue Growth Rate in Regenerative Drugs Business (2015-2020)
Figure 29. Zimmer Biomet Holdings Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Zimmer Biomet Holdings Revenue Growth Rate in Regenerative Drugs Business (2015-2020)
Figure 31. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Medtronic Revenue Growth Rate in Regenerative Drugs Business (2015-2020)
Figure 33. Athersys Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Athersys Revenue Growth Rate in Regenerative Drugs Business (2015-2020)
Figure 35. STEMCELL Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. STEMCELL Technologies Revenue Growth Rate in Regenerative Drugs Business (2015-2020)
Figure 37. Organogenesis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Organogenesis Revenue Growth Rate in Regenerative Drugs Business (2015-2020)
Figure 39. Integra Lifesciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Integra Lifesciences Revenue Growth Rate in Regenerative Drugs Business (2015-2020)
Figure 41. Acelity Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Acelity Revenue Growth Rate in Regenerative Drugs Business (2015-2020)
Figure 43. Isto Biologics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Isto Biologics Revenue Growth Rate in Regenerative Drugs Business (2015-2020)
Figure 45. CryoLife Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. CryoLife Revenue Growth Rate in Regenerative Drugs Business (2015-2020)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
Keyplayers in Global Regenerative Drugs Market Size, Status and Forecast 2020-2026
StrykerZimmer Biomet Holdings
Medtronic
Athersys
STEMCELL Technologies
Organogenesis
Integra Lifesciences
Acelity
Isto Biologics
CryoLife